CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-06 | Cartwright Daniel A CFO | Exercise or conversion | +40,000 | $0.38 | $15K | 40,000 |
| 2018-12-06 | Cartwright Daniel A CFO | Sale | −40,000 | $4.57 | $183K | 40,000 |
| 2018-12-06 | Cartwright Daniel A CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −40,000 | 180,000 | ||
| 2018-12-06 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,000 | $0.10 | $13K | 1,601,419 |
| 2018-12-06 | Milligan John C.K. IV President/Secretary | Sale | −129,000 | $4.57 | $590K | 1,472,419 |
| 2018-12-06 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,000 | 258,127 | ||
| 2018-12-04 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,000 | $0.10 | $13K | 1,601,419 |
| 2018-12-04 | Milligan John C.K. IV President/Secretary | Sale | −129,000 | $4.98 | $642K | 1,472,419 |
| 2018-12-04 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,000 | 387,127 | ||
| 2018-12-03 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-12-03 | Bernick Brian Director | Sale | −91,400 | $5.18 | $473K | 6,557,371 |
| 2018-12-03 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 183,310 | ||
| 2018-11-30 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-11-30 | Bernick Brian Director | Sale | −91,400 | $4.96 | $453K | 6,557,371 |
| 2018-11-30 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 274,710 | ||
| 2018-11-29 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,128 | $0.10 | $13K | 1,601,547 |
| 2018-11-29 | Milligan John C.K. IV President/Secretary | Sale | −129,128 | $5.03 | $650K | 1,472,419 |
| 2018-11-29 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,128 | 516,127 | ||
| 2018-11-28 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,000 | $0.10 | $13K | 1,601,419 |
| 2018-11-28 | Milligan John C.K. IV President/Secretary | Sale | −129,000 | $4.89 | $630K | 1,472,419 |
Page 17 of 24 · 463 trades